AndrewLFeldmanMD

PubMed

• Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Ly...
  Erica Mark, Werner Kempf, Joan Guitart, Melissa Pulitzer, Christina Mitteldorf, Alexandra Hristov, Carlos Torres-Cabala, Enrica Marchi, Thomas Cropley, Socorro Maria R...> ;The American Journal of Surgical Pathology. 2024 May 1
• Breast Implant Associated Anaplastic Large Cell Lymphoma: Evidence-Based Consensus Conference Statement From The American Association of Plastic Surgeons.
  Clemens, M., Di Napoli, A., Jaffe, E., Haymaker, C., Hunt, K., McCarthy, C., Miranda, R., Prince, H., Santanelli di Pompeo, F., Holmes, S., Phillips, L., Myckatyn, T.,...> ;Plastic and Reconstructive Surgery. 2024 Feb 27
• Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning.
  Tavolara, T., Niazi, M., Cooper, L., Gurcan, M., Feldman, A., Jaye, D., Flowers, C.> ;Diagnostic Pathology. 2024 Jan 19
• The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
  James R Cerhan, Matthew J Maurer, Brian K Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R C...> ;American Journal of Hematology. 2024 Mar 1
• The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, ...
  Laoruangroj, C., Atherton, P., Schumacher, P., Wiseman, G., Ansell, S., Feldman, A., Witzig, T.> ;Leukemia & Lymphoma. 2024 Mar 1
• Molecular and clinicopathological features of granzyme B-negative extranodal NK/T-cell lymphoma.
  Minh-Khang Le, Naoki Oishi, Akira Satou, Masashi Miyaoka, Ichiro Kawashima, Kunio Mochizuki, Keita Kirito, Andrew L Feldman, Naoya Nakamura, Tetsuo Kondo> ;Human Pathology. 2024 Jan 1
• Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic rel...
  L Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, Roberto Ruiz-Cordero, Francisco Vega, Andrew L Feldman, Jennifer R Chapman, Mark W Clemens, Kel...> ;Modern Pathology. 2023 Dec 1
• Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
  Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, Raphael Mwangi, Matthew Maurer, Diego Villa, Tim McDonnell, Andrew Feldman, Jonathon B Cohen, Thomas Habermann...> ;British Journal of Haematology. 2024 Jan 1
• Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
  Naoki Oishi, Reham Ahmed, Andrew L Feldman> ;Current Hematologic Malignancy Reports. 2023 Dec 1
• 1 citations
  TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
  Gongwei Wu, Noriaki Yoshida, Jihe Liu, Xiaoyang Zhang, Yuan Xiong, Tayla B Heavican-Foral, Elisa Mandato, Huiyun Liu, Geoffrey M Nelson, Lu Yang, Renee Chen, Katherine...> ;Science Translational Medicine. 2023 Sep 20
• Spinal Meningeal Mass Lesion: A Rare Presentation of Primary Dural Follicular Lymphoma.
  Jessica D White, Michelle J Clarke, Jonas Paludo, Andrew L Feldman, Ugur T Sener> ;The Neurologist. 2024 Mar 1
• Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
  Amr Fadl, Naoki Oishi, Min Shi, Surendra Dasari, Stephen M Ansell, Rhett P Ketterling, Andrew L Feldman> ;Human Pathology. 2023 Nov 1
• 1 citations
  Primary cutaneous gamma/delta T-cell lymphoma with simultaneous JAK2 and TP63 rearrangements: a new double-hit?
  Amr Fadl, N Nora Bennani, Nneka Comfere, Urshila Durani, Patricia T Greipp, Andrew L Feldman> ;Histopathology. 2023 Sep 1
• 1 citations
  Current Concepts in Nodal Peripheral T-Cell Lymphomas.
  Naoki Oishi, Andrew L Feldman> ;Surgical Pathology Clinics. 2023 Jun 1
• Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma.
  Amr Fadl, Andrew L Feldman> ;Journal of Hematopathology. 2023 Jun 1
• 1 citations
  Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
  Cristina Correia, Matthew J Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Wit...> ;Blood Cancer Journal. 2023 May 17
• 6 citations
  Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association.
  Naoki Oishi, Akira Satou, Masashi Miyaoka, Ichiro Kawashima, Takahiro Segawa, Kunio Miyake, Kunio Mochizuki, Keita Kirito, Andrew L Feldman, Naoya Nakamura, Tetsuo Kondo> ;Blood Advances. 2023 Jan 10
• Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis.
  Sanjal H Desai, Raphael Mwangi, Rebecca L King, Matthew J Maurer, James R Cerhan, Andrew L Feldman, Umar Farooq, Eric Mou, Thomas M Habermann, Carrie A Thompson, Yucai...> ;Blood Advances. 2022 Dec 27
• 54 citations
  Genomic profiling for clinical decision making in lymphoid neoplasms.
  Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William G Morice, Ryan ...> ;Blood. 2022 Nov 24
• 10 citations
  Extranodal T- and NK-cell lymphomas.
  Laurence de Leval, Andrew L Feldman, Stefano Pileri, Shigeo Nakamura, Philippe Gaulard> ;Virchows Archiv. 2023 Jan 1
• 1 citations
  Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
  Sanjal H Desai, Raphael Mwangi, Alexandra N Smith, Matthew J Maurer, Umar Farooq, Rebecca L King, James R Cerhan, Andrew L Feldman, Thomas M Habermann, Carrie A Thomps...> ;Hematological Oncology. 2023 Feb 1
• 7 citations
  Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
  Thomas A Tousseyn, Rebecca L King, Falko Fend, Andrew L Feldman, Pierre Brousset, Elaine S Jaffe> ;Virchows Archiv. 2023 Jan 1
• 16 citations
  Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
  Andrew L Feldman, Camille Laurent, Marina Narbaitz, Shigeo Nakamura, Wing C Chan, Laurence de Leval, Philippe Gaulard> ;Virchows Archiv. 2023 Jan 1
• 17 citations
  DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
  Tyler A Herek, Alyssa Bouska, Waseem Lone, Sunandini Sharma, Catalina Amador, Tayla B Heavican, Yuping Li, Qi Wei, Dylan Jochum, Timothy C Greiner, Lynette Smith, Stef...> ;Blood. 2022 Sep 15
• 435 citations
  The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
  Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, St...> ;Blood. 2022 Sep 15
• Join now to see all

Journal Articles

• Publisher Correction: Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes  
  Thomas M Habermann, Scott J Rodig, Rameen Beroukhim, Jeremiah A Wala, Andrew L Feldman, Todd R Golub, Margaret A Shipp, Nature

Abstracts/Posters

• Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Malignant T-Cells and Normal Intratumoral T-Cells Have Similar Expression of Immune Checkpoint Molecules in Angioimmunoblastic T-Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018